Business · 09/04/1998
FDA Approves New Animal Drug for Colibacillosis Treatment
The US Food and Drug Administration (FDA) has approved an abbreviated new animal drug application (ANADA) for Med-Pharmex, Inc. to use neomycin sulfate soluble powder in treating colibacillosis in cattle, swine, sheep, and goats.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →